[SYRS] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
01-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -12.03%
YoY- -13.83%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 462 454 893 412 375 370 0 -
PBT -19,455 -16,461 -18,032 -15,737 -14,047 -14,463 -15,302 17.41%
Tax 0 0 0 0 0 0 -390 -
NP -19,455 -16,461 -18,032 -15,737 -14,047 -14,463 -15,302 17.41%
Tax Rate - - - - - - - -
Total Cost 19,917 16,915 18,925 16,149 14,422 14,833 15,302 19.26%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin -4,211.04 -3,625.77 -2,019.26 -3,819.66 -3,745.87 -3,908.92 0.00 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -4.67 -4.87 -5.35 -4.68 -4.27 -4.77 -5.81 -13.58%
EPS Diluted -4.67 -4.87 -5.34 -4.68 -4.27 -4.77 -5.81 -13.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.